Regulus Therapeutics Ownership | Who Owns Regulus Therapeutics?

Overview Forecast RevenueFinancials Chart

Regulus Therapeutics Ownership Summary

Regulus Therapeutics is owned by 80.99% institutional investors, 2.69% insiders, and 16.32% retail investors. Federated hermes is the largest institutional shareholder, holding 19.63% of RGLS shares. Federated Hermes Kaufmann R is the top mutual fund, with 11.60% of its assets in Regulus Therapeutics shares.

RGLS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Regulus Therapeutics	80.99%	2.69%	16.32%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Federated hermes	12.85M	19.63%	$20.31M
Blackrock	3.97M	13.81%	$7.08M
Nea management company	6.47M	9.88%	$10.22M
Vivo capital	5.00M	7.64%	$7.90M
Octagon capital advisors lp	4.85M	7.41%	$7.66M
Blackrock funding, inc. /de	4.24M	6.47%	$6.69M
Vanguard group	3.97M	6.06%	$6.27M
Deep track capital, lp	3.26M	4.98%	$5.15M
Geode capital management	1.28M	1.95%	$2.02M
State street	1.06M	1.61%	$1.67M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Octagon capital advisors lp	4.85M	1.26%	$7.66M
Vivo capital	5.00M	0.89%	$7.90M
Cvi	401.01K	0.62%	$715.81K
Nea management company	6.47M	0.58%	$10.22M
Dafna capital management	875.20K	0.35%	$1.38M
Deep track capital, lp	3.26M	0.19%	$5.15M
Velan capital investment management lp	70.00K	0.10%	$110.60K
Federated hermes	12.85M	0.04%	$20.31M
Tyche wealth partners	106.09K	0.04%	$167.62K
Alyeska investment group	1.04M	0.01%	$1.64M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	3.97M	0.00%	3.90M
Octagon capital advisors lp	4.85M	1.26%	585.10K
Blackrock funding, inc. /de	4.24M	0.00%	155.53K
Northern trust	172.75K	0.00%	154.77K
Jpmorgan chase	190.46K	-	111.48K

Top Sellers

Holder	Shares	% Assets	Change
Millennium management	-	-	-2.19M
Price t rowe associates inc /md/	29.60K	-	-2.12M
Adage capital partners gp	-	-	-2.00M
Soleus capital management	-	-	-1.56M
Cvi	401.01K	0.62%	-1.01M

New Positions

Holder	Shares	% Assets	Change	Value
Velan capital investment management lp	70.00K	0.10%	70.00K	$110.60K
Peak6 investments	60.00K	0.00%	60.00K	$107.10K
Susquehanna group, llp	36.19K	-	36.19K	$57.18K
Intech investment management	28.48K	0.00%	28.48K	$45.00K
Bnp paribas arbitrage, snc	7.15K	-	7.15K	$11.30K

Sold Out

Holder	Change
Parallel advisors	-10.00
Continuum advisory	-300.00
Macquarie group	-865.00
Group one trading	-8.61K
Grimes & company	-10.97K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	79	12.86%	53,596,805	0.16%	80	1.21%	32	-	28	64.71%
Dec 31, 2024	69	-6.76%	53,508,278	-5.68%	81	1.09%	32	-11.11%	17	13.33%
Sep 30, 2024	74	13.85%	56,730,064	3.44%	86	1.20%	36	-10.00%	15	-6.25%
Jun 30, 2024	65	38.30%	54,841,329	20.21%	85	1.70%	40	11.11%	16	300.00%
Mar 31, 2024	47	88.00%	45,620,979	398.54%	70	35.12%	36	260.00%	4	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Federated Hermes Kaufmann R	8.02M	11.60%	143.40K
Federated Hermes Kaufmann Small Cap A	7.52M	10.87%	102.50K
Federated Hermes Kaufmann Small Cap Grow	3.07M	4.43%	102.50K
Federated Hermes Kaufmann Growth	2.82M	4.08%	143.40K
Vanguard US Total Market Shares ETF	2.50M	3.78%	-
Vanguard Total Stock Mkt Idx Inv	2.50M	3.61%	-
T. Rowe Price Health Sciences	1.68M	2.57%	1.68M
iShares Russell 2000 ETF	1.62M	2.34%	795.00
Victory Science & Technology	1.52M	2.30%	-11.22K
Vanguard Institutional Extnd Mkt Idx Tr	940.39K	1.36%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 03, 2025	Klassen Preston	President & Head of R & D	Buy	$95.85K
Jan 30, 2025	Hagan Joseph P	Chief Executive Officer	Buy	$54.26K
Jan 30, 2025	BALTIMORE DAVID	-	Buy	$20.79K
Jan 13, 2025	Aker Christopher Ray	Sr. VP & General Counsel	Sell	$48.69K
Jan 14, 2025	Aker Christopher Ray	Sr. VP & General Counsel	Sell	$6.43K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	1	-
2025 Q1	2	7
2024 Q3	1	-
2024 Q2	-	-
2024 Q1	-	3

RGLS Ownership FAQ

Who Owns Regulus Therapeutics?

Regulus Therapeutics shareholders are primarily institutional investors at 80.99%, followed by 2.69% insiders and 16.32% retail investors. The average institutional ownership in Regulus Therapeutics's industry, Biotech Stocks , is 63.96%, which Regulus Therapeutics exceeds.

Who owns the most shares of Regulus Therapeutics?

Regulus Therapeutics’s largest shareholders are Federated hermes (12.85M shares, 19.63%), Blackrock (3.97M shares, 13.81%), and Nea management company (6.47M shares, 9.88%). Together, they hold 43.32% of Regulus Therapeutics’s total shares outstanding.

Does Blackrock own Regulus Therapeutics?

Yes, BlackRock owns 13.81% of Regulus Therapeutics, totaling 3.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.08M$. In the last quarter, BlackRock increased its holdings by 3.9M shares, a 5733.89% change.

Who is Regulus Therapeutics’s biggest shareholder by percentage of total assets invested?

Octagon capital advisors lp is Regulus Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.26% of its assets in 4.85M Regulus Therapeutics shares, valued at 7.66M$.

Who is the top mutual fund holder of Regulus Therapeutics shares?

Federated Hermes Kaufmann R is the top mutual fund holder of Regulus Therapeutics shares, with 11.60% of its total shares outstanding invested in 8.02M Regulus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools